Update on management strategies for separation from cardiopulmonary bypass

Current Opinion in Anaesthesiology

Volumn 24, Issue 1, 2011, Pages 49-57

  Lombard, Frederick W ^a   Grichnik, Katherine P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clevidipine; Extracorporeal membrane oxygenation; Iloprost; Intra aortic balloon pump; Left ventricular assist device; Levosimendan; Nitric oxide; Vasopressin; Ventricular assist device

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLEVIDIPINE; DOBUTAMINE; GLYCERYL TRINITRATE; ILOPROST; LEVOSIMENDAN; MILRINONE; NEBIVOLOL; NESIRITIDE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENYLEPHRINE;

ACUTE KIDNEY FAILURE; AORTA BALLOON; ASSISTED CIRCULATION; BRADYCARDIA; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CARDIOPULMONARY HEMODYNAMICS; CARDIOPULMONARY INSUFFICIENCY; CONGESTIVE HEART FAILURE; DEVICE; DRUG HALF LIFE; DRUG MECHANISM; EXTRACORPOREAL OXYGENATION; FLUID RESUSCITATION; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART RIGHT VENTRICLE FAILURE; HUMAN; HYPERTENSION; HYPOTENSION; INTRAAORTIC BALLOON PULSATION; LEFT VENTRICULAR ASSIST DEVICE; LUNG EDEMA; MYOCARDIAL DISEASE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; REVIEW; RIGHT VENTRICULAR ASSIST DEVICE; SINGLE DRUG DOSE; VASOMOTOR DISORDER; VASOSPASM;

CARDIAC OUTPUT, LOW; CARDIOPULMONARY BYPASS; EXTRACORPOREAL MEMBRANE OXYGENATION; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; HYPERTENSION; INTRA-AORTIC BALLOON PUMPING;

EID: 79952764117     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328342064a     Document Type: Review

References (57)

1. Ailawadi G, Zacour RK. Cardiopulmonary bypass/extracorporeal membrane oxygenation/left heart bypass: indications, techniques, and complications. Surg Clin North Am 2009; 89:781-796.
2. Hernandez AF, Li S, Dokholyan S, et al. Variation in perioperative vasoactive therapy in cardiovascular surgical care: data from the Society of Thoracic Surgeons. Am Heart J 2009; 158:47-52.
3. Hogue CW, Sundt T, Barzilai B, et al. Cardiac and neurologic complications identify risks for mortality for both men and women undergoing coronary artery bypass graft surgery. Anesthesiology 2001; 95:1074-1078. (Pubitemid 33043219)
4. Rao V, Ivanov J, Weisel RD, et al. Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg 1996; 112:38.
5. Tritapepe L, De Santis V, Vitale D, et al. Levosimendan pretreatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 2009; 102:198-204.
6. Landoni G, Mizzi A, Biondi-Zoccai G, et al. Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth 2010; 24:51-57.
7. Raja SG, Rayen BS. Levosimendan in cardiac surgery: current best available evidence. Ann Thorac Surg 2006; 81:1536-1546.
8. Kersten JR, Montgomery MW, Pagel PS, Warltier DC. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg 2000; 90:5-11. (Pubitemid 30022959)
9. McBride BF, White CM. Levosimendan: implications for clinicians. J Clin Pharmacol 2003; 43:1071-1081. (Pubitemid 37174438)
10. Ruel M, Khan TA, Voisine P, et al. Vasomotor dysfunction after cardiac surgery. Eur J Cardiothorac Surg 2004; 26:1002-1014. (Pubitemid 39433886)
11. Levin MA, Lin HM, Castillo JG, et al. Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome. Circulation 2009; 120:1664-1671. An article that discusses a problem that every anesthesiologist deals with frequently upon separation from CPB.
12. Lavigne D. Vasopressin and methylene blue: alternate therapies in vasodilatory shock. Semin Cardiothorac Vasc Anesth 2010; 14:186-189. A therapy everyone should know about - both benefits and risks.
13. Dellinger RP, Carlet JM, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873. (Pubitemid 38344143)
14. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999; 15:816-822.
15. Winterhalter M, Simon A, Fischer S, et al. Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomized trial. J Cardiothorac Vasc Anesth 2008; 22:406-413.
16. Olschewski H, Rose F, Schermuly R, et al. Prostacyclin and its analogues in the treatment of pulmonary hypertension. Pharmacol Ther 2004; 102:139-153. (Pubitemid 38681013)
17. Hoeper MM, Olschewski H, Ghofrani HA, et al. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol 2000; 35:176-182. (Pubitemid 30061277)
18. Kopman EA, Ramirez-Inawat RC. Intra-aortic balloon counterpulsation for right heart failure. Anesth Analg 1980; 59:74-76. (Pubitemid 10183147)
19. Liakopoulos OJ, Ho JK, Yezbick AB, et al. Right ventricular failure resulting from pressure overload: role of intra-aortic balloon counterpulsation and vasopressor therapy. J Surg Res 2010; 164:58-66.
20. Desai RG, Muntazar M, Golberg ME. Strategies for managing perioperative hypertension. Curr Hypertens Rep 2009; 11:173-177. A good overview of therapeutic agents available for management of perioperative hypertension.
21. Aronson S, Dyke CM, Stierer KA, et al. The ECLIPSE trials: comparative studies of clevidipine to nitroglycerine, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg 2008; 107:1110-1121.
22. Patel M, Meyer T, Tharakan A, Tobias JD. Intraoperative administration of clevidipine to prevent vasospasm after radial and internal mammary artery grafts during coronary artery bypass grafting. Am J Ther. doi: 10.1097/MJT.0b013e3181e907b9. [Epub ahead of print]
23. Marcus LS, Hart D, Packer M, et al. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1996; 94:3184-3189.
24. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005; 111:1487-1491. (Pubitemid 40470642)
25. Lingegowda V, Van QC, Shimada M, et al. Long-term outcome of patients treated with prophylactic nesiritide for the prevention of acute kidney injury following cardiovascular surgery. Clin Cardiol 2010; 33: 217-221.
26. Blais DM. Nesiritide compared with milrinone for cardiac surgery. Ann Pharmacother 2007; 41:502-504. (Pubitemid 46536043)
27. Dessy C, Saliez J, Ghisdal P, et al. Endothelial 3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third generation beta-blocker nebivolol. Circulation 2005; 112:1198-1205. (Pubitemid 41216127)
28. Lavana JD, Fraser JF, Smith SE, et al. Influence of timing of intraaortic balloon placement in cardiac surgical patients. J Thorac Cardiovasc Surg 2010; 140:80-85.
29. Dhaliwal AS, Chu D, Huh J, et al. Prognostic impact of intra-aortic balloon pump insertion before versus after cardiac surgical intervention in a veteran population. Am J Surg 2009; 198:628-632. It is exceedingly important to determine who will most benefit from preoperative placement of an IABP.
30. Zaky SS, Hanna AH, Sakr Esa WA, et al. An 11-year, single-institution analysis of intra-aortic balloon pump use in cardiac surgery. J Cardiothorac Vasc Anesth 2009; 23:479-483.
31. Diez C, Silber RE, Wachner M, et al. EuroSCORE directed intraaortic balloon pump placement in high-risk patients undergoing cardiac surgery: retrospective analysis of 267 patients. Interact Cardiovasc Thorac Surg 2008; 7:389-395. (Pubitemid 351769053)
32. Etienne PY, Papadatos S, Glineur D, et al. Reduced mortality in high-risk coronary patients operated off pump with preoperative intraaortic balloon counterpulsation. Ann Thorac Surg 2007; 84:498-502. (Pubitemid 47069195)
33. Zattera G, Totaro P, D'Armini AM, Viganò M. Intra aortic balloon pump insertion through left axillary artery in patients with severe peripheral arterial disease. Interact Cardiovasc Thorac Surg 2009; 9:369-370. An alternative cannulation site for IABP that all cardiothoracic anesthesiologists should be aware of.
34. Cochran P, Starkey TD, Panos AL, Kunzelman KS. Ambulatory intraaortic balloon pump use as bridge to heart transplant. Ann Thorac Surg 2002; 74:746-752.
35. Boeken U, Feindt P, Litmathe J, et al. Intraaortic balloon pumping in patients with right ventricular insufficiency after cardiac surgery: parameters to predict failure of IABP Support. Thorac Cardiovasc Surg 2009; 57:324-328.
36. Atwater BD, Nee LM, Gimelli G. Percutaneous right ventricular assist device for biventricular mechanical support of cardiogenic shock. J Invasive Cardiol 2008; 20:E205-E207.
37. Nicolini F, Gherli T. Alternatives to transplantation in the surgical therapy for heart failure. Eur J Cardiothorac Surg 2009; 35:214-228.
38. Lasala JM, Mehran R, Moses JW, et al. Evidence based management of patients undergoing PCI. Catheter Cardiovasc Interv 2010; 75 (Suppl 1):S43-S45.
39. Kucukaksu S, Ergenoglu MU, Yildiz CE, et al. High-risk left main coronary artery bypass surgery supported by the Impella Recover LP 2.5 assist device: an alternative insertion technique. Heart Surg Forum 2009; 12:E324-E326.
40. Vranckx P, Schultz CJ, Valgimigli M, et al. Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG. Catheter Cardiovasc Interv 2009; 74:302-310.
41. CardiacAssist, Inc and Abiomed Inc., Danvers, MA. http://www.abiomed.com. [Accessed 20 October 2010]
42. Terracciano CM, Leslie W, Miller LW, Yacoub MH. Contemporary use of ventricular assist devices. Ann Rev Med 2010; 61:255-270. An article on the use of VADs from the medical point of view.
43. Cook S, Windecker S. Percutaneous left ventricular assist devices during cardiogenic shock and high-risk percutaneous coronary interventions. Curr Cardiol Rep 2009; 11:369-376. There is increasing use of percutaneous VADs for surgical and other procedures.
44. Stassano P, Di Tommaso L, Monaco M, et al. Myocardial revascularization by left ventricular assisted beating heart is associated with reduced systemic inflammatory response. Ann Thorac Surg 2009; 87:46-52.
45. Pitsis AA, Visouli AN, Burkhoff D, et al. Feasibility study of a temporary percutaneous left ventricular assist device in cardiac surgery. Ann Thorac Surg 2007; 84:1993-1999. (Pubitemid 350122402)
46. Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist devices vs intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 2009; 30:2102-2108.
47. Unosawa S, Hata M, Sezai A, et al. Successful recovery using surgical intervention to treat ischemic cardiomyopathy and cardiogenic shock. Ann Thorac Cardiovasc Surg 2010; 16:52-54.
48. Mountis MM, Starling RC. Management of left ventricular assist devices after surgery: bridge, destination, and recovery. Curr Opin Cardiol 2009; 24:252-256. An excellent review of the uses for LVADs.
49. Alba C, Delgado DH. The future is here: ventricular assist devices for the failing heart: types of VADs. Expert Rev Cardiovasc Ther 2009; 7:1067-1077 http://www.medscape.com/viewarticle/709956-2. [Accessed 20 October 2010]
50. Osaki S, Edwards NM, Johnson MR, Kohmoto T. A novel use of the implantable ventricular assist device for isolated right heart failure. Interact Cardiovasc Thorac Surg 2008; 7:651-653.
51. Loforte A, Montalto A, Della Monica PL, Musumeci F. Simultaneous temporary CentriMag right ventricular assist device placement in HeartMate II left ventricular assist system recipients at high risk of right ventricular failure Interact. Cardiovasc Thorac Surg 2010; 10:847-850.
52. Velik-Salchner C, Hoermann C, Hoefer D, et al. Thromboembolic complications during weaning from right ventricular assist device support. Anesth Analg 2009; l109:354-357.
53. Luo XJ, Wang W, Hu SS, et al. Extracorporeal membrane oxygenation for treatment of cardiac failure in adult patients. Interact Cardiovasc Thorac Surg 2009; 9:296-300.
54. Fux T, Svenarud P, Grinnemo KH, et al. Extracorporeal membrane oxygenation as a rescue of intractable ventricular fibrillation and bridge to heart transplantation. Eur J Heart Fail 2010; 12:301-304. A good review of the uses for ECMO.
55. Rastan AJ, Dege A, Mohr M, et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 2010; 139:302-311; 311.e1.
56. Risnes I, Wagner K, Ueland T, et al. Interleukin-6 may predict survival in extracorporeal membrane oxygenation treatment. Perfusion 2008; 23:173-178.
57. Xu LF, Li X, Guo Z, et al. Extracorporeal membrane oxygenation during doublelung transplantation: single center experience. Chin Med J 2010; 123:269-273.